WEIKANG BIO-TECHNOLOGY GROUP CO., INC. (CIK: 0001484042) EDGAR, Information, Filings... CompaniesBIO.Com

WEIKANG BIO-TECHNOLOGY GROUP CO., INC.

Mailing address
NO. 25 CHENGDE STREET, DAWAI DISTRICT, HARIN, HEILONGJIANG PROVINCE, Nevada, 150020
Phone
86 0451 88355530
State location
China
State of incorporation
Nevada
Fiscal year end
December 31
SIC
2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Filings
N/A

WEIKANG BIO-TECHNOLOGY GROUP CO., INC. (CIK: 0001484042) is an American company incorporated in the state of China. Head office is located at NO. 25 CHENGDE STREET, DAWAI DISTRICT, HARIN, HEILONGJIANG PROVINCE, China, 150020. Work in the industry 2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS. WEIKANG BIO-TECHNOLOGY GROUP CO., INC. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Chuang Jeffrey	0001535501	Apr-08-2011	director
Sun Baolin	0001497536	Jul-23-2010	officer: Chief Financial Officer
Wang Yin	0001421489	Jun-29-2010	director, 10 percent owner, officer: Chief Executive Officer
Lucky Wheel Ltd.	0001497933	Jun-29-2010	10 percent owner
Wang Weili	0001421491	Jun-16-2010	10 percent owner, officer: Vice President of Finance
ZHANG YVONNE	0001409895	Apr-07-2010	director
Jin Yilun	0001446308	Apr-07-2010	director
Zhang Allen	0001489551	Apr-07-2010	director
Huang Yan	0001489553	Apr-07-2010	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by WEIKANG BIO-TECHNOLOGY GROUP CO., INC.

Filings	Format	Description	Filed/Effective	File/Film Number
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-12-067374 (34 Act) Size: KB	Dec-11-2012	000-54814 121255930
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-12-067107 (34 Act) Size: KB	Dec-10-2012	000-54814 121251847
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001144204-12-062205 (34 Act) Size: KB	Nov-14-2012	000-54814 121202785
8-A12G	Document	Form for registration of a class of securities pursuant to section 12(g) Acc-no: 0001144204-12-052899 (34 Act) Size: KB	Sep-25-2012	000-54814 121109477
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-12-049073 (34 Act) Size: KB	Aug-30-2012	333-165684 121066629
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-12-045503 (34 Act) Size: KB	Aug-14-2012	333-165684 121031904
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-12-029203 (34 Act) Size: KB	May-15-2012	333-165684 12842519
8-K	Document	Current report filing Acc-no: 0001144204-12-019658 (34 Act) Size: KB	Apr-03-2012	333-165684 12735781
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001144204-12-018721 (34 Act) Size: KB	Mar-30-2012	333-165684 12728613
8-K	Document	Current report filing Acc-no: 0001144204-12-007142 (34 Act) Size: KB	Feb-10-2012	333-165684 12590111
UPLOAD	Document	Acc-no: 0000000000-12-002631 ( Act) Size: KB	Jan-18-2012
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001144204-11-071956 ( Act) Size: KB	Dec-28-2011
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001144204-11-071954 (34 Act) Size: KB	Dec-28-2011	333-165684 111284471
10-Q/A	Document	Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-11-071952 (34 Act) Size: KB	Dec-28-2011	333-165684 111284465
UPLOAD	Document	Acc-no: 0000000000-11-071606 ( Act) Size: KB	Dec-14-2011
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001489553-11-000003 ( Act) Size: 0 KB	Nov-30-2011
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001489551-11-000002 ( Act) Size: 0 KB	Nov-30-2011
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001535501-11-000001 ( Act) Size: 0 KB	Nov-30-2011
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-11-066046 (34 Act) Size: KB	Nov-21-2011	333-165684 111218280
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001144204-11-064835 (34 Act) Size: KB	Nov-15-2011	333-165684 111205826

Recent 20 filings. View all WEIKANG BIO-TECHNOLOGY GROUP CO., INC. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

WEIKANG BIO-TECHNOLOGY GROUP CO., INC. overview
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. job
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. stock
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. ownership
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. CEO
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.